Mumps Vaccine (MumpsVax) Market Report 2026
Download Free Sample Buy Now
Mumps Vaccine (MumpsVax) Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Mumps Vaccine (MumpsVax) Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Mumps Vaccine (MumpsVax) Market Overview

• The Mumps Vaccine (MumpsVax) market growth in the historic period has been driven by high incidence of mumps outbreaks, introduction of routine childhood immunization

• Market expansion is supported by need to prevent re-emerging outbreaks, strengthening of school immunization policies

• Growth Driver: Mumps Resurgence Highlights Need For Boosters Amid Waning Vaccine Protection

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Mumps Vaccine (MumpsVax) Market?

Mumps vaccine (MumpsVax) is a live attenuated vaccine that prevents mumps using the Jeryl Lynn strain of the virus. Administered in two doses, it is often combined with the MMR (measles, mumps, rubella) vaccine and provides over 95% protection against mumps. Although standalone production has ceased, mumps vaccine (mumpsvax) remains crucial for public health efforts to reduce mumps outbreaks and has significantly lowered incidence rates in vaccinated populations.

The main product types of mumps vaccine (mumpsvax) are monovalent, combinational, divalent, trivalent, and others. Monovalent vaccines target only mumps, while combinational vaccines protect against multiple diseases, such as measles and rubella, in one shot. The age group includes pediatrics and adults, and distribution channels are hospital pharmacies, drug stores, and retail pharmacies. It is used by various end-users such as pediatric clinics, hospitals, non-governmental organizations (NGOs), and other end-users.

Mumps Vaccine (MumpsVax) Market Global Report 2026 Market Report bar graph

What Is The Mumps Vaccine (MumpsVax) Market Size and Share 2026?

The growth in the historic period can be attributed to high incidence of mumps outbreaks, introduction of routine childhood immunization, effectiveness of live attenuated vaccines, public health vaccination mandates, decline in disease burden after vaccination.

What Is The Mumps Vaccine (MumpsVax) Market Growth Forecast?

The growth in the forecast period can be attributed to need to prevent re-emerging outbreaks, strengthening of school immunization policies, expansion of global vaccination coverage, focus on herd immunity maintenance, public health surveillance improvements. Major trends in the forecast period include sustained demand for combination vaccines, focus on pediatric immunization programs, continued use in outbreak control strategies, integration with national immunization schedules, emphasis on long-term population immunity.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Mumps Vaccine (MumpsVax) Market Segmentation

1) By Product Type: Monovalent, Combinational, Divalent, Trivalent, Other Product Types

2) By Age Group: Pediatric, Adult

3) By Distribution Channels: Hospital pharmacies, Drug Stores, Retail Pharmacies

4) By End-User: Pediatric Clinic, Hospitals, Non-Governmental Organization (NGOs), Other End-Users

What Are The Drivers Of The Mumps Vaccine (MumpsVax) Market?

Rising prevalence of infectious diseases is expected to propel the growth of the mumps vaccine (mumpsvax) market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms, such as viruses, bacteria, fungi, or parasites, that can be transmitted from one individual to another or through contaminated environments. The increase in the prevalence of infectious diseases is primarily driven by factors such as urbanization, climate change, globalization, and changes in human demographics and behavior, which enhance the transmission and emergence of pathogens. Mumpsvax, a mumps vaccine, is primarily used to prevent mumps infection, which is an infectious disease caused by the mumps virus, often included in the MMR (measles, mumps, rubella) vaccination. For instance, in August 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, in 2023, the West Midlands region reported the highest number of measles cases, with 160 cases (44%), followed by London with 122 cases (33%). Notably, children under the age of 10 represented 63% of the total cases, amounting to 232 cases. Measles activity saw a significant rise towards the end of the year, with 157 new cases recorded in December, compared to just 45 cases in November. Therefore, the rise in the prevalence of infectious diseases is driving the mumps vaccine (mumpsvax) industry.

Rising healthcare expenditure is expected to propel the growth of the mumps vaccine (mumpsvax) market going forward. Healthcare expenditure refers to the total amount spent on health care goods and services, including personal health care, preventive services, and public health activities, aimed at improving health outcomes within a specific period. The rising healthcare expenditure is due to an aging population, chronic diseases, advanced medical technology, high drug prices, inefficient payment models, and increased demand for services. Rising healthcare expenditure affects mumps vaccine (mumpsvax) by boosting funding for vaccination initiatives, which can improve access to the vaccine and lead to better public health outcomes through increased immunization rates against mumps. For instance, in May 2024, according to a report published by Office for National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, total long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, the rising healthcare expenditure is driving the mumps vaccine (mumpsvax) industry.

The increasing number of clinical trials is expected to propel the growth of the mumps vaccine (mumpsvax) market going forward. Clinical trials play a crucial role in advancing the understanding and treatment of Acute Spinal Cord Injury (SCI). Mumpsvax provides targeted immunity against the mumps virus that helps clinical trials by serving as a reliable tool for evaluating vaccine efficacy, safety, and immune response, particularly in studies focused on viral infections and pediatric immunization strategies. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that the total number of clinical trials initiated in the UK rose from 411 in 2022 to 426 in 2023. Therefore, the increasing number of clinical trials drives the mumps vaccine (mumpsvax) industry.

Key Players In The Global Mumps Vaccine (MumpsVax) Market

Major companies operating in the mumps vaccine (mumpsvax) market are Merck & Co. Inc., GlaxoSmithKline plc

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the mumps vaccine (mumpsvax) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Mumps Vaccine (MumpsVax) Market?

The mumps vaccine (mumpsvax) market consists of sales of mumps vaccines, including both standalone mumps vaccines and combination vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Mumps Vaccine (MumpsVax) Market Report 2026?

The mumps vaccine (mumpsvax) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mumps vaccine (mumpsvax) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Mumps Vaccine (MumpsVax) Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product Type, Age Group, Distribution Channels, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Merck & Co. Inc., GlaxoSmithKline plc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Mumps Vaccine (MumpsVax) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Mumps Vaccine (MumpsVax) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Mumps Vaccine (MumpsVax) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Mumps Vaccine (MumpsVax) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Sustained Demand For Combination Vaccines

4.2.2 Focus On Pediatric Immunization Programs

4.2.3 Continued Use In Outbreak Control Strategies

4.2.4 Integration With National Immunization Schedules

4.2.5 Emphasis On Long-Term Population Immunity

5. Mumps Vaccine (MumpsVax) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Pediatric Clinics

5.3 Public Health Departments

5.4 Vaccination Centers

5.5 Non-Governmental Organizations

6. Mumps Vaccine (MumpsVax) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Mumps Vaccine (MumpsVax) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Mumps Vaccine (MumpsVax) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Mumps Vaccine (MumpsVax) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Mumps Vaccine (MumpsVax) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Mumps Vaccine (MumpsVax) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Mumps Vaccine (MumpsVax) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Mumps Vaccine (MumpsVax) Market Segmentation

9.1. Global Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monovalent, Combinational, Divalent, Trivalent, Other Product Types

9.2. Global Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric, Adult

9.3. Global Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital pharmacies, Drug Stores, Retail Pharmacies

9.4. Global Mumps Vaccine (MumpsVax) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric Clinic, Hospitals, Non-Governmental Organization (NGOs), Other End-Users

10. Mumps Vaccine (MumpsVax) Market Regional And Country Analysis

10.1. Global Mumps Vaccine (MumpsVax) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Mumps Vaccine (MumpsVax) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Mumps Vaccine (MumpsVax) Market

11.1. Asia-Pacific Mumps Vaccine (MumpsVax) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Mumps Vaccine (MumpsVax) Market

12.1. China Mumps Vaccine (MumpsVax) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Mumps Vaccine (MumpsVax) Market

13.1. India Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Mumps Vaccine (MumpsVax) Market

14.1. Japan Mumps Vaccine (MumpsVax) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Mumps Vaccine (MumpsVax) Market

15.1. Australia Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Mumps Vaccine (MumpsVax) Market

16.1. South Korea Mumps Vaccine (MumpsVax) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Mumps Vaccine (MumpsVax) Market

17.1. Western Europe Mumps Vaccine (MumpsVax) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Mumps Vaccine (MumpsVax) Market

18.1. UK Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Mumps Vaccine (MumpsVax) Market

19.1. Germany Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Mumps Vaccine (MumpsVax) Market

20.1. France Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Mumps Vaccine (MumpsVax) Market

21.1. Eastern Europe Mumps Vaccine (MumpsVax) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Mumps Vaccine (MumpsVax) Market

22.1. North America Mumps Vaccine (MumpsVax) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Mumps Vaccine (MumpsVax) Market

23.1. USA Mumps Vaccine (MumpsVax) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Mumps Vaccine (MumpsVax) Market

24.1. Canada Mumps Vaccine (MumpsVax) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Mumps Vaccine (MumpsVax) Market

25.1. South America Mumps Vaccine (MumpsVax) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Mumps Vaccine (MumpsVax) Market

26.1. Middle East Mumps Vaccine (MumpsVax) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Mumps Vaccine (MumpsVax) Market

27.1. Africa Mumps Vaccine (MumpsVax) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Segmentation By Age Group, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Mumps Vaccine (MumpsVax) Market Regulatory and Investment Landscape

29. Mumps Vaccine (MumpsVax) Market Competitive Landscape And Company Profiles

29.1. Mumps Vaccine (MumpsVax) Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Mumps Vaccine (MumpsVax) Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Mumps Vaccine (MumpsVax) Market Company Profiles

29.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

29.3.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

30. Global Mumps Vaccine (MumpsVax) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Mumps Vaccine (MumpsVax) Market

32. Mumps Vaccine (MumpsVax) Market High Potential Countries, Segments and Strategies

32.1 Mumps Vaccine (MumpsVax) Market In 2030 - Countries Offering Most New Opportunities

32.2 Mumps Vaccine (MumpsVax) Market In 2030 - Segments Offering Most New Opportunities

32.3 Mumps Vaccine (MumpsVax) Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Mumps Vaccine (MumpsVax) Market, Overview Of Key Products - Product Examples
  • Table 2: Global Mumps Vaccine (MumpsVax) Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Mumps Vaccine (MumpsVax) Market, Supply Chain Analysis
  • Table 4: Global Mumps Vaccine (MumpsVax) Market, Major Raw Material Providers
  • Table 5: Global Mumps Vaccine (MumpsVax) Market, Major Resource Providers
  • Table 6: Global Mumps Vaccine (MumpsVax) Market, Major Manufacturers (Suppliers)
  • Table 7: Global Mumps Vaccine (MumpsVax) Market, Major Distributors And Channel Partners
  • Table 8: Global Mumps Vaccine (MumpsVax) Market, Key Technologies & Future Trends
  • Table 9: Global Mumps Vaccine (MumpsVax) Market, Major Trends
  • Table 10: Global Mumps Vaccine (MumpsVax) Market, Major End Users
  • Table 11: Global Mumps Vaccine (MumpsVax) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Mumps Vaccine (MumpsVax) Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Mumps Vaccine (MumpsVax) Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Mumps Vaccine (MumpsVax) Market - TAM, US$ Billion, 2025
  • Table 15: Global Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Mumps Vaccine (MumpsVax) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Mumps Vaccine (MumpsVax) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Mumps Vaccine (MumpsVax) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: South Korea, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Western Europe, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: UK, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Germany, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: France, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Eastern Europe, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: North America, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: USA, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Canada, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: South America, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Middle East, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Africa, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Global Mumps Vaccine (MumpsVax) Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 73: Global Mumps Vaccine (MumpsVax) Market - Company Scoring Matrix
  • Table 74: Merck & Co. Inc. Financial Performance
  • Table 75: GlaxoSmithKline plc Financial Performance
  • Table 76: Global Mumps Vaccine (MumpsVax) Market, Competitive Benchmarking (In USD Billions)
  • Table 77: Global Mumps Vaccine (MumpsVax) Market, Competitive Dashboard
  • Table 78: Global Mumps Vaccine (MumpsVax) Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 79: Global, Mumps Vaccine (MumpsVax) Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Table 80: Global, Mumps Vaccine (MumpsVax) Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030
  • Table 81: Global, Mumps Vaccine (MumpsVax) Market Size Gain ($ Billion), Segmentation By Distribution Channels, 2025 – 2030

List Of Figures

    Figure 1: Global Mumps Vaccine (MumpsVax) Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Mumps Vaccine (MumpsVax) Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Mumps Vaccine (MumpsVax) Market, Supply Chain Analysis
  • Figure 4: Global Mumps Vaccine (MumpsVax) Market, Major Raw Material Providers
  • Figure 5: Global Mumps Vaccine (MumpsVax) Market, Major Resource Providers
  • Figure 6: Global Mumps Vaccine (MumpsVax) Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Mumps Vaccine (MumpsVax) Market, Major Distributors And Channel Partners
  • Figure 8: Global Mumps Vaccine (MumpsVax) Market, Key Technologies & Future Trends
  • Figure 9: Global Mumps Vaccine (MumpsVax) Market, Major Trends
  • Figure 10: Global Mumps Vaccine (MumpsVax) Market, Major End Users
  • Figure 11: Global Mumps Vaccine (MumpsVax) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Mumps Vaccine (MumpsVax) Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Mumps Vaccine (MumpsVax) Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Mumps Vaccine (MumpsVax) Market - TAM, US$ Billion, 2025
  • Figure 15: Global Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Mumps Vaccine (MumpsVax) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Mumps Vaccine (MumpsVax) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Mumps Vaccine (MumpsVax) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: South Korea, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Western Europe, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: UK, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Germany, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: France, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Eastern Europe, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: North America, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: USA, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Canada, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: South America, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Middle East, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Africa, Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Global Mumps Vaccine (MumpsVax) Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 73: Global Mumps Vaccine (MumpsVax) Market - Company Scoring Matrix
  • Figure 74: Merck & Co. Inc. Financial Performance
  • Figure 75: GlaxoSmithKline plc Financial Performance
  • Figure 76: Global Mumps Vaccine (MumpsVax) Market, Competitive Benchmarking (In USD Billions)
  • Figure 77: Global Mumps Vaccine (MumpsVax) Market, Competitive Dashboard
  • Figure 78: Global Mumps Vaccine (MumpsVax) Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 79: Global, Mumps Vaccine (MumpsVax) Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Figure 80: Global, Mumps Vaccine (MumpsVax) Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030
  • Figure 81: Global, Mumps Vaccine (MumpsVax) Market Size Gain ($ Billion), Segmentation By Distribution Channels, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Dendritic Cell Cancer Vaccine Market Report 2026 - Global Outlook – By Product (CreaVax, Sipuleucel-T (Provenge), Other Products), By Distribution Channel (Hospitals, Cancer Centers, Ambulatory Surgical Centers, Clinics)...

Porcine Epidemic Diarrhea Vaccines Market Report 2026 - Global Outlook – By Product (Live Vaccines, Killed Vaccines), By Application (Piglets, Adults Pigs), By End-User (Veterinary Hospitals, Hog Production Farms) – Mark...

mRNA Cancer Vaccines And Therapeutics Market Report 2026 - Global Outlook – By Type (Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas), By Application (Cancer, Other Applications), By End User (Hospitals A...

Tetanus Toxoid Vaccine Market Report 2026 - Global Outlook – By Vaccine Type (Tetanus Toxoid (TT), Diphtheria And Tetanus (DT), Tetanus And Diphtheria (Td), Diphtheria, Tetanus, And Pertussis (Dtap), Tetanus, Diphtheria,...

Yellow Fever Vaccine Market Report 2026 - Global Outlook – By Product (Powder, Liquid), By Application (Routine Immunization, Travelers, Other Applications), By End-User (Hospitals, Diagnostic Centers, Point Of Care Cent...

Multivalent Vaccines Market Report 2026 - Global Outlook – By Type (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines), By Disease (Influenza, Pneumonia...

Personalized Cancer Vaccines Market Report 2026 - Global Outlook – By Treatment Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Pro...

Influenza Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Age Group (Pediatric,...

Frequently Asked Questions

The Mumps Vaccine (MumpsVax) market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Mumps Vaccine (MumpsVax) market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Mumps Vaccine (MumpsVax) market Include, Merck & Co. Inc., GlaxoSmithKline plc .

Major trend in this market includes: nan. For further insights on this market. request a sample here

North America was the largest region in the mumps vaccine (mumpsvax) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mumps vaccine (mumpsvax) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us